| Literature DB >> 34219748 |
Ahmed H Sadek1,2, Mohsen S Asker3, Sayeda A Abdelhamid3.
Abstract
Nanoscale zero-valent iron particles were investigated as an antibacterial agent against two Gram-positive bacteria; Staphylococcus aureus NRRL B-313 (S. aureus), Bacillus subtilus NRC (B. subtilus), and two Gram-negative bacteria; Escherichia coli NRC B-3703 (E. coli), Pseudomonas aeruginosa NRC B-32 (Ps. aeruginosa). The characterization of synthesized nZVI particles was obtained by XRD, SEM, EDX, and TG analyses. The results demonstrated that the nZVI particles have a spherical shape, mean crystalline size of 44.43 nm, and exhibited a good chemical and thermal stability performance under different physical conditions. The bacterial suspensions were subjected to the treatment using nZVI particle suspensions with a concentration of 10 mg/mL. The minimum inhibitory concentration of nZVI particles was determined using the well diffusion assay method and found to be 15, 10, 10, and 5 mg for the following four strains; S. aureus, B. subtilus, E. coli, and Ps. aeruginosa, respectively. The biological treatment results of municipal wastewater using nZVI particles revealed that the counts of total bacteria, total coliform, fecal coliform, S. aureus, fecal Streptococcus, and E. coli were decreased to 44.29%, 51.76%, 90.95%, 46.67%, 33.33%, and 93.89%, respectively, while the Ps. aeruginosa not detected in the wastewater sample. The enhanced inactivation performance of nZVI nanoparticles was mainly attributed to the reactive oxygen species (ROS) production, releasing of iron corrosion products like Fe2+/Fe3+ ions, and direct friction of nZVI particles with bacterial cells membranes. In addition, the nZVI particles presented a striking disinfection behavior in comparison with other widespread disinfection technologies such as chlorination. Accordingly, the obtained results introduce the nZVI particles as a promising disinfection technology. © Institute of Molecular Biology, Slovak Academy of Sciences 2021.Entities:
Keywords: Antimicrobial activity; Escherichia coli; Microbial contamination; Municipal wastewater; Nanoscale zero-valent iron; Pathogens bacteria; Pseudomonads
Year: 2021 PMID: 34219748 PMCID: PMC8237559 DOI: 10.1007/s11756-021-00814-w
Source DB: PubMed Journal: Biologia (Bratisl) ISSN: 0006-3088 Impact factor: 1.350
Waterborne infectious pathogen bacteria potentially present in untreated domestic wastewater and their health effects in water supplies (EPA 2012; Water and Organization 2006; Division et al. 2004)
| Pathogen Bacteria | Health Significance | Persistence in Water Supplies a | Resistance to Chlorine b | Relative Infectivity c | Diseases | Numbers in Raw Wastewater (per liter) |
|---|---|---|---|---|---|---|
| Low | May multiply | Low | Low | Melioidosis also called Whitmore’s disease | ||
| High | Moderate | Low | Moderate | Gastroenteritis, reactive arthritis | ||
| High | Moderate | Low | Low | Gastroenteritis and septicemia, hemolytic uremic syndrome (HUS) | ||
| High | Moderate | Low | High | Bloody diarrhea | ||
| High | Multiply | Low | Moderate | Respiratory illness (pneumonia, Pontiac fever) | ||
| Non-tuberculous mycobacteria | Low | Multiply | High | Low | Pulmonary disease resembling tuberculosis, lymphadenitis, skin disease | |
| Moderate | May multiply | Moderate | Low | Skin, eye, ear infections | ||
| High | Moderate | Low | Low | Typhoid fever | Up to 105 | |
| Other salmonellae | High | May multiply | Low | Low | Salmonellosis | |
| High | Short | Low | Moderate | Shigellosis (bacillary dysentery) | Up to 104 | |
| High | Short | Low | Low | Cholera | Up to 105 | |
| High | Long | Low | Low | Yersiniosis |
aDetection period for the infective stage in water at 20 °C: short, up to 1 week; moderate, 1 week to 1 month; long, over 1 month
bWhen the infective stage is freely suspended in water treated at conventional doses and contact times. Resistance moderate, the agent may not be completely destroyed
cFrom experiments with human volunteers or from epidemiological evidence
dIncludes enteropathogenic, enterotoxigenic, and enteroinvasive
eMain route of infection is by skin contact but can infect immunosuppressed or cancer patients orally
Fig. 1Flowchart for synthesis process of nZVI nanoparticles
Physical and chemical properties of the raw municipal wastewater sample and equivalent recommended requirements for reusing the reclaimed water in the different purposes (Shoushtarian and Negahban-Azar 2020; Division et al. 2004; Blumenthal et al. 2000; Ayers and Westcot 1985)
| Items | Unit | Raw Wastewater Results | Reclaimed Water Limitations | ||||
|---|---|---|---|---|---|---|---|
| USEPA (2012) 1 | FAO 2 | WHO 3 | ISO (2015) 4 | ||||
| Long-term Use | Short-term Use | ||||||
| Temperature | °C | 22.0 | – | – | – | – | – |
| pH | – | 7.16 | 6 | – | – | – | – |
| Dissolved Oxygen (DO) | mg-O2/L | 0.87 | – | – | – | – | – |
| Biological Oxygen Demand (BOD) | mg-O2/L | 189 | 30≥ | – | – | – | – |
| Chemical Oxygen Demand (COD) | mg-O2/L | 315 | – | – | – | – | – |
| Total Suspended Solids (TSS) | mg/L | 204 | 30≥ | – | – | – | – |
| Oils & Grease | mg/L | 0.29 | – | – | – | – | – |
| Total Nitrogen (TN) | mg-N/L | 39.5 | – | – | – | – | – |
| Total Phosphorus (TP) | mg-P/L | 2.90 | – | – | – | – | – |
| Sulfides (H2S) | mg-S/L | 2.70 | – | – | – | – | – |
| Free Cyanide (CN−) | mg-CN/L | 0.02 | – | – | – | – | – |
| Phenol | mg/L | 0.002 | – | – | – | – | – |
| Aluminum (Al) | mg/L | 0.001 | 5.0 | 20 | 5.0 | – | – |
| Arsenic (As) | mg/L | 0.011 | 0.10 | 2.0 | 0.10 | – | – |
| Boron (B) | mg/L | 0.008 | 0.75 | 2.0 | – | – | – |
| Cadmium (Cd) | mg/L | 0.0013 | 0.01 | 0.05 | 0.01 | – | – |
| Chromium (Cr) | mg/L | 0.009 | 0.1 | 1.0 | 0.10 | – | – |
| Copper (Cu) | mg/L | 0.039 | 0.2 | 5.0 | 0.20 | – | – |
| Iron (Fe) | mg/L | 0.109 | 5.0 | 20.0 | 5.0 | – | – |
| Mercury (Hg) | mg/L | 0.0058 | – | – | – | – | – |
| Nickel (Ni) | mg/L | 0.011 | 0.2 | 2.0 | 0.20 | – | – |
| Silver (Ag) | mg/L | 0.01 | – | – | – | – | – |
| Zinc (Zn) | mg/L | 0.087 | 2.0 | 10.0 | 2.0 | – | – |
| Lead (Pb) | mg/L | 0.11 | 5.0 | 10.0 | 5.0 | – | – |
| Fecal Coliform | CFU/100 mL | 2100 | ≤ 200 a | 800 a | ≤ 103 b | ≤ 103 | ≤ 103 c |
| CFU/100 mL | 1800 | ≤ 200 d | ≤ 104 d | – | ≤ 103 e | – | |
1 Recommended limits for constituents in reclaimed water for agricultural reuse, USEPA (2004)
2 Recommended maximum concentrations according to the FAO guidelines for trace metals in irrigation water (Adapted from National Academy of Sciences (1972) and Pratt (1972)
3 Guidelines for the microbiological quality of treated wastewater used in agriculture: recommendations for revising WHO guidelines
4 ISO 16075-1:2015 Guidelines for treated wastewater use for irrigation projects — Part 1: The basis of a reuse project for irrigation
a Processed food crops/non-food crops
b Geometric mean
c High-quality treated wastewater; restricted urban irrigation and agricultural irrigation of processed food crops
d Global reclaimed water quality standards (non-food crops)
e Unrestricted (Drip irrigated, Low-growing)
Fig. 2(a) XRD pattern of nZVI particles, Symbol: (•) indicate to Fe0 peaks, (b) SEM image of nZVI particles, (c) Typical EDX of nZVI particles
Properties of the synthesized nZVI particles
| Color | Shape | Average Particle Size (nm) | Theoretical Specific Surface Area (m2/kg) |
|---|---|---|---|
| Black | Spherical | 44.43 | 17.31 |
Fig. 3Thermogravimetric plot (TGA) of nZVI particles
Fig. 4Weight loss (%) of nZVI particles at; (a) different pH, (b) different temperatures
Fig. 5Schematic drawing representing the antibacterial mechanisms of nZVI particles
Fig. 6Inhibition zones of (a) Bacillus subtilus, (b) Staphylococcus aureus, (c) Escherichia coli, (d) Pseudomonas aeruginosa as detected by well diffusion assay method
Inhibition zone of nZVI particles and the other antimicrobial agents from the literature
| Antimicrobial Agent | Concentrations | Particle Size (nm) | Pathogens Bacteria | Inhibition Zone (mm) | References |
|---|---|---|---|---|---|
Biosynthesized AgNPs synthesized using | 200–300-500 μg/mL | 4.24–23.2 | 13–15-25 13–15-17 13–15-17 12–15-17 13–15-17 13–14-15 | Moustafa ( | |
Zinc oxide nanoparticles - ZnO-1, - ZnO-2, - ZnO-3 | 20–100 μg/mL | 41.60–51.43 70.27–167.61 52.15–76.42 | 18–21 25–30 13–17 | Narayanan et al. ( | |
Zinc oxide nanoparticles synthesized using - Mechano-chemical method - Sol-gel method | 15–25-50 mM 50 mM | 10–20 5–7 | 8–10-12 10 | Elmi et al. ( | |
Zinc oxide nanoparticles - Bulk ZnO - Chemical ZnO - Green ZnO | 2–4-6 mM | 25 40 | 14–17-23 18–20-27 18–22-31 | Gunalan et al. ( | |
| Bio(AgNPs) produced by | 100 μg/mL | 8–48 | 6 10 10 6 | Buszewski et al. ( | |
- 4A zeolite, - ZnO/4A zeolite, - TiO2/4A zeolite, - TiO2/ZnO/4A zeolite nanocomposites | 1–4 mg/mL | 400–600 for 4A zeolite 10–50 for TiO2/ZnO | 0, 6.21, 7.58, 9.22 0, 6.86, 9.13, 10.73 | Azizi-Lalabadi et al. ( | |
α-Fe2O3/Co3O4 nanocomposites - FeK4 | 800 μg/mL | 25.34 | 21 24 26 | Bhushan et al. ( | |
| Cerium oxide nanoparticles | 100 μg/mL | 45 | 3 1 | Pelletier et al. ( | |
| CuO/C nanocomposites | 1 mg/mL | 7–11 | 11 12 11 | Bhavyasree and Xavier ( | |
| nZVI nanoparticles | 0.1 g/mL | 44.43 | 14 9 18 21 | This study |
Minimal inhibitory concentration of nZVI particles determined by the well diffusion assay with substance concentration in (μL)
| Sample | Concentration (mg) | Gram (+ve) | Gram (−ve) | ||
|---|---|---|---|---|---|
| nZVI nanoparticles | 2.5 | 0 | 0 | 0 | 0 |
| 5.0 | 0 | 0 | 0 | 11 | |
| 7.5 | 0 | 0 | 0 | 16 | |
| 10 | 0 | 14 | 21 | 18 | |
| 15 | 20 | – | 23 | – | |
| 20 | 22.5 | – | 26 | – | |
| 22.5 | 25 | – | 33 | – | |
Minimal inhibitory concentration (MIC) of nZVI particles and the other antimicrobial agents from the literature
| Antimicrobial Agent | Pathogens Bacteria | Concentrations | MIC at 24 h | References |
|---|---|---|---|---|
| ZnO nanoparticles | 20–100 μg/mL | 40 μg/mL | Dimapilis et al. ( | |
Zinc oxide nanoparticles synthesized using - Mechano-chemical method - Sol-gel method | – | 1017 μg/mL | Elmi et al. ( | |
Zinc oxide nanoparticles - Chemical ZnO - Green ZnO | 0.01–10 mM | 0.80 mM 0.40 mM | Gunalan et al. ( | |
| Bio(AgNPs) produced by | 100 μg/mL | 6.25 μg/mL 6.25 μg/mL 6.25 μg/mL 25 μg/mL | Buszewski et al. ( | |
| Biosynthesized of silver and zinc nanoparticles extracellular synthesis using | 10 mg/mL | Ag NPs – Zn NPs 5–2.5 mg/mL ˃10 - ˃10 mg/mL 2.5–5 mg/mL 2.5 - ˃10 mg/mL | Punjabi et al. ( | |
| 4A zeolite, TiO2/4A zeolite, ZnO/4A zeolite, TiO2/ZnO/4A zeolite nanocomposites | 1–4 mg/mL | 0, 3, 3, 2 mg/mL 0, 2, 2, 1 mg/mL | Azizi-Lalabadi et al. ( | |
| Magnesium oxide-germanium oxide nanocomposite | 50 mg/mL | 0.05 mg/mL at 16 h 0.25 mg/mL at 16 h | Avanzato et al. ( | |
| nZVI nanoparticles | 2.5–22.5 mg/20 mL | 15 mg/mL 10 mg/mL 10 mg/mL 5 mg/mL | This study |
Fig. 7Effect of nZVI particles concentrations (mg/mL) on bacteria of the wastewater sample as determined by optical density assay
Fig. 8Impact of nZVI particles on growth inhibition of Gram (+) and Gram (−) bacteria in the municipal wastewater sample
Antibacterial activity of nZVI particles against microorganisms of the sewage water
| Tested Bacteria | Before Treatment by nZVI Nanoparticles | After Treatment by nZVI Nanoparticles | Growth Inhibition (%) |
|---|---|---|---|
Total bacteria CFU/mL at 35 °C | 420 | 243 | 44.29 |
Total bacteria CFU/mL at 22 °C | 463 | 314 | 32.18 |
Total coliform CFU/100 mL | 34,000 | 16,400 | 51.76 |
| 14,100 | 9400 | 33.33 | |
Fecal coliform CFU/100 mL | 2100 | 190 | 90.95 |
CFU/100 mL | 1200 | 640 | 46.67 |
CFU/100 mL | 1800 | 110 | 93.89 |
| ND* | ND | ND |
* ND: Not detected
Reductions of bacteria achieved by typical and enhanced water treatment processes compared with nZVI as a disinfecting agent (Water and Organization 2006)
| Treatment Process | Baseline Removal | Maximum Removal Possible |
|---|---|---|
| Roughing filters | 50% | Up to 95% if protected from turbidity spikes by dynamic filter or if used only when ripened |
| Microstraining | Zero | Generally ineffective |
| Off-stream/bankside storage | Zero (assumes short-circuiting) | 90% removal in 10–40 days actual detention time |
| Bankside infiltration | 99.9% after 2 m 99.99% after 4 m (minimum based on virus removal) | |
| Conventional clarification | 30% | 90% (depending on the coagulant, pH, temperature, alkalinity, turbidity) |
| High-rate clarification | At least 30% | |
| Dissolved air flotation | No data available | |
| Lime softening | 20% at pH 9.5 for 6 h at 2–8 °C | 99% at pH 11.5 for 6 h at 2–8 °C |
| Zero | ||
| Granular high-rate filtration | No data available | 99% under optimum coagulation conditions |
| Slow sand filtration | 50% | 99.5% under optimum ripening, cleaning and refilling and in the absence of short-circuiting |
| Precoat filtration, including diatomaceous earth and perlite | 30–50% | 96–99.9% using chemical pretreatment with coagulants or polymers |
| Membrane filtration – microfiltration | 99.9–99.99%, providing adequate pretreatment and membrane integrity conserved | |
| Membrane filtration – ultrafiltration, nanofiltration and reverse osmosis | Complete removal, providing adequate pretreatment and membrane integrity conserved | |
| Chlorine | Ct99: 0.08 mg·min/l at 1–2 °C, pH 7; 3.3 mg·min/l at 1–2 °C, pH 8.5 | |
| Monochloramine | Ct99: 94 mg·min/l at 1–2 ° C, pH 7; 278 mg·min/l at 1–2 °C, pH 8.5 | |
| Chlorine dioxide | Ct99: 0.13 mg·min/l at 1–2 °C, pH 7; 0.19 mg·min/l at 1–2 °C, pH 8.5 | |
| Ozone | Ct99: 0.02 mg·min/l at 5 °C, pH 6–7 | |
| UV irradiation | 99% inactivation: 7 mJ/cm2 | |
| nZVI nanoparticles * | 44.29% at 35 °C for 24 h; 32.18% at 22 °C for 24 h | |
Note: Ct and UV apply to microorganisms in suspension, not embedded in particles or in biofilm
*This study
Suggested considerations for reclaimed water reuse focusing on microbiological aspect according to the WHO recommendations and the EPA regulatory guidelines comparing with results obtained by nZVI nanoparticles (EPA 2012; Blumenthal et al. 2000)
| Reuse Category | Treatment | Microbiological Reclaimed Water Quality (2) | |||
|---|---|---|---|---|---|
| EPA Guidelines | Treatment Goal in Reclaimed Water (13) | WHO & FAO (14) | nZVI Nanoparticles * | ||
•Total coliforms: <1 CFU/100 mL - 200 CFU/100 mL •Fecal coliforms: <1 CFU/100 mL - 103 CFU/100 mL | •Fecal Coliforms (CFU/100 mL): •˂200 (g) •˂1000 (m) (15) | •16,400 total coliform CFU/100 mL •190 fecal coliform CFU/100 mL •No Cl2 residual | |||
| Unrestricted | •Secondary (3) •Filtration (4) •Disinfection (5) | •No detectable fecal coliform /100 mL (6, 7) •1 mg/L Cl2 residual (min.) (8) | |||
| Restricted | •Secondary (3) •Disinfection (5) | • ≤ 200 fecal coliform /100 mL (6, 9, 10) •1 mg/L Cl2 residual (min.) (8) | |||
| Food Crops (11) | •Secondary (3) •Filtration (4) •Disinfection (5) | •No detectable fecal coliform/100 mL (6, 7) •1 mg/L Cl2 residual (min.) (8) | |||
| Processed Food Crops (11) | •Secondary (3) •Disinfection (5) | • ≤ 200 fecal coliform /100 mL (6, 9, 10) •1 mg/L Cl2 residual (min.) (8) | |||
| Non-Food Crops | •Secondary (3) •Disinfection (5) | • ≤ 200 fecal coliform /100 mL (6, 9, 10) •1 mg/L Cl2 residual (min.) (8) | |||
| Unrestricted | •Secondary (3) •Filtration (4) •Disinfection (5) | •No detectable fecal coliform/100 mL (6, 7) •1 mg/L Cl2 residual (min.) (8) | |||
| Restricted | •Secondary (3) •Disinfection (5) | • ≤ 200 fecal coliform/100 mL (6, 9, 10) •1 mg/L Cl2 residual (min.) (8) | |||
| Environmental Reuse | •Variable •Secondary (3) and disinfection (5) (min.) | • ≤ 200 fecal coliform/100 mL (6, 9, 10) •1 mg/L Cl2 residual (min.) (8) | |||
| Once-through Cooling | •Secondary (3) | • ≤ 200 fecal coliform/100 mL (6, 9, 10) •1 mg/L Cl2 residual (min.) (8) | |||
| Recirculating Cooling Towers | •Secondary (3) •Disinfection (5) (chemical coagulation and filtration (4) may be needed) | • ≤ 200 fecal coliform/100 mL (6, 9, 10) •1 mg/L Cl2 residual (min.) (8) | |||
| The use of reclaimed water to recharge aquifers which are not used as a potable drinking water source | •Site-specific and use-dependent •Primary (min.) for spreading •Secondary (3) (min.) for injection | •Site-specific and use-dependent | |||
| Groundwater Recharge by Spreading into Potable Aquifers | •Secondary (3) •Filtration (4) •Disinfection (5) •Soil aquifer treatment | •No detectable total coliform/100 mL (6, 7) •1 mg/L Cl2 residual (min.) (8) | |||
| Groundwater Recharge by Injection into Potable Aquifers | •Secondary (3) •Filtration (4) •Disinfection (5) •Advanced wastewater treatment (12) | •No detectable total coliform/100 mL (6, 7) •1 mg/L Cl2 residual (min.) (8) | |||
| Augmentation of Surface Water Supply Reservoirs | •Secondary (3) •Filtration (4) •Disinfection (5) •Advanced wastewater treatment (12 | •No detectable total coliform/100 mL (6, 7) •1 mg/L Cl2 residual (min.) (8) | |||
(1) These guidelines are based on water reclamation and reuse practices in the U.S. and are specifically directed at states that have not developed their own regulations or guidelines. While the guidelines should be useful in many areas outside the U.S., local conditions may limit the applicability of the guidelines in some countries. It is explicitly stated that the direct application of these suggested guidelines will not be used by USAID as strict criteria for funding
(2) Unless otherwise noted, recommended quality limits apply to the reclaimed water at the point of discharge from the treatment facility
(3) Secondary treatment process includes activated sludge processes, trickling filters, rotating biological contractors, and may stabilization pond systems. Secondary treatment should produce effluent in which both the BOD and SS do not exceed 30 mg/l.
(4) Filtration means; the passing of wastewater through natural undisturbed soils or filter media such as sand and/or anthracite; or the passing of wastewater through microfilters or other membrane processes
(5) Disinfection means the destruction, inactivation, or removal of pathogenic microorganisms by chemical, physical, or biological means. Disinfection may be accomplished by chlorination, ozonation, other chemical disinfectants, UV, membrane processes, or other processes
(6) Unless otherwise noted, recommended coliform limits are median values determined from the bacteriological results of the last 7 days for which analyses have been completed. Either the membrane filter or fermentation tube technique may be used
(7) The number of total or fecal coliform organisms (whichever one is recommended for monitoring in the table) should not exceed 14/100 ml in any sample
(8) This recommendation applies only when chlorine is used as the primary disinfectant. The total chlorine residual should be met after a minimum actual modal contact time of at least 90 min unless a lesser contact time has been demonstrated to provide indicator organism and pathogen reduction equivalent to those suggested in these guidelines. In no case should the actual contact time be less than 30 min
(9) The number of fecal coliform organisms should not exceed 800/100 ml in any sample
(10) Some stabilization pond systems may be able to meet this coliform limit without disinfection
(11) Commercially processed food crops are those that, prior to sale to the public or others, have undergone chemical or physical processing sufficient to destroy pathogens
(12) Advanced wastewater treatment processes include chemical clarification, carbon adsorption, reverse osmosis, and other membrane processes, advanced oxidation, air stripping, ultrafiltration, and ion exchange
(13) Adapted from Lazarova, 2001; Metcalf and Eddy, 1991; Pettygrove and Asano, 1985 (EPA 2004) (Division et al. 2004)
(14) WHO microbiological quality guidelines for wastewater use in agriculture (Organization WH 2006), report of the WHO/AFESD regional consultation to review national priorities and action plans for wastewater reuse and management in the Eastern Mediterranean Region (WHO-EM/CEH/106/E) (Organization WH 2004), and FAO recommended microbiological quality guidelines for wastewater use in agriculture (Pescod 1992)
(15) (g) signifies that the standard is a guideline and the water is appropriate for public lawns, such as hotel lawns, with which the public may come into direct contact, while (m) signifies that the standard is a mandatory regulation
*This study
Comparison of growth inhibition efficiency of nZVI particles and the other antimicrobial agents from the literature against different pathogenic bacterial strains
| Antimicrobial Agent | Pathogens Bacteria | Concentrations | Growth Inhibition, % | References |
|---|---|---|---|---|
| Silver nanoparticles coated with polyurethane foam | Total coliform Fecal coliform | 1118.6 mg/L | 98.5% at 48 h 100% at 48 h 99.9% at 24 h 99.9% at 24 h | Moustafa ( |
| Magnesium oxide-germanium oxide nanocomposite | >5 mg/mL | >95% at 16 h | Avanzato et al. ( | |
| MgO nanoparticles | 3 mg/mL | 100% at 24 h | Tang and Lv ( | |
Novel nystatin conjugated iron oxide nanocomposite - Nys-CS-MNP | 2 mg/mL | 1.312% at 24 h 35.08% at 24 h 99.09% at 24 h | Hussein-Al-Ali et al. ( | |
| nZVI nanoparticles | Total coliform Fecal coliform | 2–5 mg/mL | 51.76% at 48 h 90.95% at 48 h 46.67% at 48 h 33.33% at 48 h 93.89% at 48 h ND | This study |